Injectable Tumoricidal Neural Stem Cell-Laden Hydrogel for Treatment of Glioblastoma Multiforme—An In Vivo Safety, Persistence, and Efficacy Study

Background/Objectives: Glioblastoma multiforme (GBM) is the most common high-grade primary brain cancer in adults. Despite efforts to advance treatment, GBM remains treatment resistant and inevitably progresses after first-line therapy. Induced neural stem cell (iNSC) therapy is a promising, persona...

詳細記述

書誌詳細
主要な著者: Jasmine L. King, Alain Valdivia, Shawn D. Hingtgen, S. Rahima Benhabbour
フォーマット: 論文
言語:English
出版事項: MDPI AG 2024-12-01
シリーズ:Pharmaceutics
主題:
オンライン・アクセス:https://www.mdpi.com/1999-4923/17/1/3